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First  neuroimaging  study  on disgust  and fear experiences  in  Parkinson’s  disease.
Patients  were  nondemented,  nondepressed  and  nonmedicated  during  the experiment.
Despite  long  disease  duration  no indication  of  diminished  brain  activation  and emotion  experience.
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Objective:  Amygdala  abnormalities  have  been  discussed  as  a possible  mechanism  underlying  reduced
reactivity  to negative  stimuli  in  Parkinson’s  disease  (PD).
Methods:  The  present  investigation  used  functional  magnetic  resonance  imaging  (fMRI)  in order  to test
this hypothesis.  We  compared  brain  activation  of 17  nondepressed  and  nondemented  PD  patients  with
22  healthy  controls  during the  elicitation  of negative  affective  states.  The  patients  suffered  from  moderate
motor  symptoms  for  an average  of  75  months  and  had  stopped  their  antiparkinson  medication  10–12 h
prior  to  the  fMRI  testing.  All  participants  were shown  images  which  depicted  disgusting,  fear-relevant
and  neutral  contents  and  they  answered  self-report  scales  for the  assessment  of disgust  proneness  and
trait anxiety.
Results: Both  groups  did  not  differ  from  each  other  in  affective  state  and  trait  ratings.  In line with  the self-MRI report,  the  fMRI  data  showed  similar  activation  (including  the amygdala)  in  both  groups  during  disgust
and  fear  elicitation.
Conclusion:  This  fMRI  investigation  found  no  indication  of  diminished  disgust  and  fear  experience  in  PD.
Signiﬁcance:  Previously  reported  affective  processing  deﬁcits  in  PD might  be due  to insufﬁciently  con-
trolled  confounding  variables  (medication,  depression,  cognitive  impairment).
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Parkinson’s disease (PD) is a neurodegenerative disease related
o progressive degeneration of nigrostriatal dopaminergic path-
ays. While motor problems such as tremor, rigidity, and
radykinesia are key symptoms of this syndrome, impairments
n emotional functioning additionally have been reported (for a
eview see Peron et al. [1]).A variety of tests have been applied to analyze PD-related difﬁ-
ulties in affective processing. There are numerous studies on facial
motion recognition in PD. Surprisingly these studies produced
∗ Corresponding author at: University of Graz, Universitätsplatz 3, A-8010 Graz,
ustria.
E-mail address: Anne.schienle@uni-graz.at (A. Schienle).
ttp://dx.doi.org/10.1016/j.neulet.2015.10.046
304-3940/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
very heterogeneous outcomes. Whereas some authors reported
general or at least emotion-speciﬁc deﬁcits, others observed no
problems at all (for a review see Gray et al. [2]).
Other investigations focused on the experience of emotions,
which were elicited by affective scenes. The ﬁndings of those stud-
ies which combined self-report with electro-cortical and startle
measures were also mixed, but rather pointed to a diminished
experience of aversive feelings in PD patients [3–6].
Dietz et al. [4] conducted an event-related potential (ERP) study
and presented the participants with (un) pleasant and neutral
images. The authors focused on the late positive potential (LPP),
which is a reliable electrophysiological index of emotional per-
ception that originates in visual cortex regions. The LPP amplitude
increases with the experienced intensity of the affective stimulus.
Therefore, the LPP is considered an indicator of motivated atten-
tion, in which survival-relevant stimuli draw automatic attention
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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n order to facilitate perceptual processing [7]. The results showed
hat PD patients’ LPP amplitude for unpleasant pictures did not dif-
er from the neutral condition and was smaller than those of control
articipants. This effect was interpreted as reduced LPP modula-
ion to aversive stimuli in the clinical group. However, patients and
ontrols did not differ in their valence and arousal ratings for the
ictures.
A discrepancy between ERP ﬁndings and explicit ratings for
ffective pictures had also been observed by Wieser et al. [6]. PD
atients experienced arousing pictures as less intense than healthy
ontrols, although they had displayed comparable ERP waveforms.
In experiments with the startle paradigm, the participants are
resented with a sudden loud noise while looking at affective
cenes (pleasant, unpleasant, and neutral). The elicited emotional
tate inﬂuences the strength of the startle reﬂex. Aversive emo-
ional states have been shown to potentiate this reﬂex, whereas
ppetitive emotional states are inhibitors. Bowers et al. [3] reported
hat relative to healthy controls the startle reﬂex amplitude was
electively reduced in PD patients when presented with aversive
ictures. As the startle reﬂex is mediated by the amygdala, the
uthors speculated that PD patients show reduced amygdala acti-
ation during the processing of threatening information.
Amygdala abnormalities are often discussed as a possible
echanism underlying PD-related emotional dysfunctions (e.g.,
essitore et al. [8]). Further, it has been proposed that frontal
rain regions (e.g., orbitofrontal cortex (OFC)) show activation
hanges due to degeneration-based changes of striatal input. These
ypotheses can be directly tested via functional magnetic reso-
ance imaging (fMRI). To the best of our knowledge this is the
rst neuroimaging study to investigate neuronal and subjective
esponses to affective scenes in PD. We  tested nondepressed,
nd nondemented patients, who had discontinued their Parkin-
on medication for 10–12 h prior to experiment. The patients were
ompared with healthy controls during emotion elicitation. All
articipants were shown images which depicted disgusting, fear-
elevant and neutral contents. They were asked to rate the intensity
f experienced emotions and to answer questionnaires for the
ssessment of affective traits (disgust proneness and trait anxiety).
e expected that PD patients would show reduced activation of
he amygdala, basal ganglia and prefrontal regions (e.g., OFC) dur-
ng the viewing of aversive scenes and that they would rate the
ictures as less intense than the control group.
. Methods
.1. Participants
Seventeen PD patients (8 women, 9 men) and 22 healthy con-
rols (11 women, 11 men) participated in this study. All patients had
een diagnosed with idiopathic PD by neurologists of the University
ospital in Graz (Austria).
The clinical and the control groups did not differ in mean
ge (MPD = 55.2 years (9.4)), MCO = 51.8 years (9.8), t(37) = 1.12
p = 0.272), years of education (MPD = 13.4 years (3.4)), MCO = 13.9
3.9), t(37) = 0.42 (p = 0.679), and did not show signs of cognitive
mpairment as assessed by the Test for Early Detection of Demen-
ia (MPD = 46.2 (1.9); MCO = 44.6 (3.1), t(38) = 1.88, p = 0.068). The
cores of this scale [9] range between 0 and 50; a score below 35
ndicates a tentative dementia diagnosis. The scores on the rat-
ng scale by Hoehn and Yahr [10] were either 2.0 (14 patients) or
.0 (3 patients). Eleven PD patients had right body side onset of
otor symptoms and 6 had left-side onset. The patients had a sum
core on the Uniﬁed Parkinson’s Disease Rating Scale of M = 36.1
SD = 13.0) ranging between 17 and 49 [11]. This implies mild toetters 609 (2015) 142–146 143
moderate motor impairment. The symptom duration was on aver-
age M = 75.4 months (SD = 43.7).
With one exception all patients were treated with L-Dopa and/
or a dopamine agonist (pramipexole, ropinirole). Medication was
discontinued overnight for 10–12 h prior to the fMRI experiment
and later continued.
Written informed consent was  obtained from each participant.
The study was carried out in accordance with the Declaration of
Helsinki and had been approved by the Ethics Committee of the
Medical University of Graz.
2.2. Questionnaires
All participants answered the following trait scales: The Ques-
tionnaire for the Assessment of Disgust Proneness (QADP, [12])
measures disgust propensity and describes 37 situations, which
have to be judged on 5-point scales with regard to the experienced
disgust (0, ‘not disgusting’; 4, ‘very disgusting’). The QADP has ﬁve
subscales (death, spoilage, poor hygiene, oral rejection, body secre-
tions) for the assessment of domain-speciﬁc disgust proneness. The
Cronbach’s alpha for the subscales varies between 0.69 and 0.87
(total scale = 0.90). The trait scale of the State-Trait Anxiety Inven-
tory (STAI; [13]) measures the frequency of anxious feelings. The
questionnaire consists of 20 items which are answered on 4-point
scales (1 = almost never, 4 = almost ever). The Cronbach’s alpha of
the scale is 0.88. The Beck Depression Inventory (BDI, [14] consists
of 21 items rated on 4-point scales. A sum score of 18 or higher
indicates clinical relevance. This questionnaire was applied since
depressive tendencies inﬂuence affective processing.
2.3. Stimuli and design
In this experiment the participants were asked to view 10 dis-
gusting (e.g. dirty toilets, maggots), 10 fear-eliciting (attacks by
humans and animals) and 10 neutral pictures (e.g. nature scenes,
geometric ﬁgures) from a validated set [12] with the instruction to
simply experience the elicited emotions. There was no speciﬁc task.
The pictures were presented in blocks of 10 pictures each taken
from the same affective category. Each picture was  shown for 3 s.
Thus, the block duration was  30 s. In total, 9 blocks were shown
as each block was repeated twice. The block sequence was  pseudo-
randomized. This fMRI methodology represents a mixed design. We
had introduced the restriction that two  categories of the same type
were not allowed to follow each other. Between the blocks a ﬁx-
ation cross was  shown for 5 s. Consequently, the total experiment
lasted 310 s. The short duration was  chosen in order to allow the
patients to stay still during scanning. This was achieved; none of
the patients had to be excluded from the sample due to movement
artefacts.
Subsequent to the fMRI experiment, the participants gave affec-
tive ratings for the pictures. For each image they indicated the
intensity of experienced disgust and fear (Please indicate how
intensely you experienced disgust/fear 1 = very little, 9 = very intense).
2.4. fMRI: recording and analysis
Brain images were acquired using a 3 Tesla Siemens Tri-
oTim (Siemens, Erlangen, Germany) with a 12-channel head
coil. For the functional runs a total of 164 volumes were
acquired by using an echo-planar imaging protocol (35 descend-
ing slices; slice thickness: 3 mm;  TE = 30 ms; TR = 2300 ms;  voxel
size: 3.0 × 3.0 × 3.0 mm;  FoV: 192; ﬂip angle: 90◦; slice orientation
−25◦ tilted from the AC–PC line). To account for saturation effects
3 slices from the beginning of the time series were discarded.
All analyses were conducted using SPM12 (Wellcome Depart-
ment of Cognitive Neurology, London). For compensating ﬁeld
1 ence Letters 609 (2015) 142–146
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Table 1
Self-report data on affective states and traits.
PD CG t p
Affective traits
QADP 1.92 (0.44) 1.99 (0.53) 0.46 0.650
Death 1.14 (0.99) 0.94 (0.69) 0.74 0.460
Spoilage/decay 1.56 (0.62) 1.91 (0.60) 1.81 0.079
Body  secretions 2.36 (0.54) 2.39 (0.80) 0.12 0.902
Poor  hygiene 2.05 (0.58) 2.40 (0.62) 1.78 0.083
Oral  rejection 1.91 (0.44) 1.99 (0.53) 0.64 0.528
BDI  9.35 (7.77) 6.55 (4.39) 1.43 0.162
STAI 39.24 (11.7) 32.73 (9.02) 1.96 0.057
Affective states (intensity ratings)
Disgust pictures
Disgust 5.90 (1.16) 5.56 (1.87) 0.63 0.531
Fear  2.82 (1.62) 2.26 (1.42) 1.14 0.262
Fear  pictures
Disgust 2.64 (1.33) 2.22 (1.27) 1.01 0.321
Fear  6.93 (1.32) 5.43 (2.39) 2.27 0.029
Neutral pictures
Disgust 1.33 (0.43) 1.29 (0.54) 0.25 0.807
Fear  1.76 (1.22) 1.35 (0.78) 1.15 0.221
QADP: Questionnaire for the Assessment of Disgust Proneness; BDI: Beck Depression
Inventory; STAI: State Trait Anxiety Inventory (trait scale).
Table 2
ROI activation during the viewing of affective scenes.
hem. x y z t p(FWE) Cluster size
Patients: Disgust > Neutral
Amygdala L -21 -6 -12 3.49 0.025 15
Amygdala R 27 -6 -12 3.18 0.017 3
DLPFC R 51 42 15 6.69 0.005 214
DMPFC R 6 54 45 4.33 0.047 113
OFC  L -24 36 -12 8.38 <0.001 176
OFC  R 27 33 -9 5.02 0.035 47
VLPFC L -24 36 -12 8.38 <0.001 166
VLPFC R 51 39 15 8.09 <0.001 555
Patients: Fear > Neutral
No signiﬁcant ROI activation
Controls: Disgust > Neutral
Amygdala L -18 -6 -12 4.02 0.006 13
Amygdala R 21 -3 -18 4.48 0.002 26
Pallidum L -27 -12 -6 3.01 0.047 10
Putamen R 27 -6 -9 3.59 0.039 71
Controls: Fear > Neutral
Amygdala L -27 -9 -12 3.07 0.036 5
Amygdala R 21 -3 -15 3.21 0.029 14
Group comparison Controls > Patients: Fear > Neutral44 A. Schienle et al. / Neurosci
nhomogeneity we applied a ﬁeldmap during the pre-subtracted
hase and magnitude step in SPM12. Afterwards images were
otion-corrected via realignment and to account for acquisition
iming subsequent we set a slice timing step. Individuals’ t1 images
ere co-registered to the functional mean image and ﬁnally seg-
ented into gray matter (GM) and white matter (WM).  To create
 study-speciﬁc template and to increase inter-subject alignment
 ‘Fast Diffeomorphic Registration Algorithm’ (DARTEL) was exe-
uted with GM and WM images. Resulting images were further
ormalized to MNI-space (3 mm isotropic voxel), and smoothed
ith an 8 mm isotropic Gaussian kernel. Data were high pass ﬁl-
ered (128 s) and temporal sphericity was controlled by an AR(1)
rocess with consecutive pre-whitening of the data.
In the ﬁrst level analysis we computed t-contrasts for dif-
erent conditions (Fear > Neutral, Disgust > Neutral, Fear > Disgust
nd Disgust > Fear). For a comparison of patients and controls
esulting images were afterwards submitted to two sample t-tests
omparing voxel intensities. We  conducted an exploratory whole
rain analysis as well as a region of interest (ROI) analysis for
he amygdala, insula, dorsolateral/ ventrolateral prefrontal cor-
ex (DLPFC, VLPFC), and basal ganglia (caudate nucleus, putamen,
allidum). The uncorrected height threshold for the analyses was
et to p < 0.005. Voxel–peaks are reported when p corrected for
amily-wise error (FWE) <0.05 (small volume correction). The ROI
asks were taken from the Harvard-Oxford Cortical and Subcorti-
al Structural Atlas (Center for Morphometric Analysis, MGH-East,
oston/MA, USA) and from the Juelich histological atlas [15].
We tested the following hypotheses: Relative to controls:
(a) PD patients show lower amygdala activation in the Fear and
Disgust condition.
b) PD patients show lower prefrontal activation (OFC, DLPFC,
DMPFC, and VLPFC) in the Fear and Disgust condition.
Additionally, we investigated whether PD patients show gener-
lly lower activation in basal ganglia regions (putamen, pallidum,
audate nucleus) as these are the ﬁrst targets of neurodegeneration.
. Results
Self-reports: The two groups did not differ in disgust prone-
ess, trait anxiety and depression (Table 1). The affective ratings
howed that the intended emotions were elicited with sufﬁcient
ntensity and speciﬁcity. In both groups, the target emotion always
eceived higher intensity ratings than the non-target emotion (all
’s < 0.001). The clinical and the control group did not differ in their
ffective ratings, when correcting for multiple comparisons (Bon-
erroni corrected signiﬁcance cutoff; see Table 1).
fMRI: During the viewing of disgusting images (contrast: Dis-
ust > Neutral) the patients showed ROI activation in the amygdala
nd several prefrontal regions (OFC, DLPFC, VLPFC). The whole-
rain analysis revealed activation of the middle occipital gyrus
MNI coordinates x, y, z: −21, −87, 12; t = 10.16, p(FWE) < 0.001,
luster size (number of voxels) = 770). The control group recruited
he amygdala, putamen, and pallidum (ROIs), and the calcarine
ssure (whole brain analysis; x, y, z: −6, −84, −3, t = 8.85,
(FWE) < 0.001, cluster size = 661) during disgust elicitation. All ROI
esults are depicted in Table 2.
In the fear condition (Fear > Neutral) the controls activated the
mygdala, whereas the patients displayed no statistically signiﬁ-
ant ROI activation (Fig. 1). For this contrast, the patients showed
ctivation of the middle temporal gyrus (x, y, z: 48, −72, 3, t = 9.81,
(FWE) < 0.001, cluster size = 314) as revealed by the whole brain
nalysis.Pallidum R 18 3 -3 4.26 0.002 32
hem. = hemisphere; MNI  coordinates, p(FWE) corrected for family-wise error.
The group comparison indicated one signiﬁcant difference for
Fear > Neutral. The controls showed stronger pallidum recruit-
ment than the patients. The contrasts Disgust > Neutral as well as
Fear > Disgust and Disgust > Fear indicated no statistically signiﬁ-
cant group differences, neither on the whole-brain level nor for the
ROIs. (The control group had shown marginally stronger pallidum
activation (p = 0.10) than controls for Disgust > Neutral).
4. Discussion
This fMRI investigation found no indication of diminished dis-
gust and fear experience in patients suffering from moderate PD
symptoms. The selected pictures had induced the target emotions
with sufﬁcient intensity and speciﬁcity in patients as well as in
controls. Both groups did not differ in their affective ratings. Simi-
lar ﬁndings have been reported by Dietz et al. [16]. The participants
of this study (PD patients and healthy controls) had been presented
A. Schienle et al. / Neuroscience Letters 609 (2015) 142–146 145
sting 
w
s
o
b
P
e
n
w
u
d
c
t
i
b
t
T
‘
f
[
d
t
d
t
(
u
a
c
i
n
w
f
tFig. 1. Brain activation of PD patients and controls while viewing disgu
ith affective pictures while changes of pupil size as an indicator of
ympathetic arousal were recorded. Neither the subjective ratings
f the images (valence, arousal) nor the pupillary responses differed
etween the groups. In the same vein, Vicente et al. [17] found that
D patients at different stages of the disease reported comparable
motional experience to ﬁlm excerpts for the elicitation of happi-
ess, anger, fear, sadness, and disgust as controls. Previous studies
hich had identiﬁed diminished responses to aversive visual stim-
li in PD patients had also often observed higher apathy and/or
epression scores compared to controls (e.g., Wieser et al. [6]). Thus,
onfounding effects of these variables cannot be excluded.
In line with the comparable ratings of patients and controls in
he present study, the brain activation during the picture view-
ng did also not differ between patients and controls. The whole
rain approach indicated enhanced visual cortex activation when
he participants looked at affective relative to neutral pictures.
his effect has been interpreted in the theoretical framework of
motivated attention’: more extensive visual system activation
acilitates perceptual processing of survival-relevant information
7]. No group differences were observed.
The PD group displayed additional activation of the amyg-
ala and several prefrontal regions (OFC, DLPFC, and VLPFC) in
he disgust condition. This activation pattern has previously been
escribed for healthy subjects (e.g., Schienle et al. [12]). The men-
ioned areas are involved in the assignment of affective value
amygdala, OFC) and are recruited during attempts of emotion reg-
lation (DLPFC, VLPFC). The control group showed activation of the
mygdala and basal ganglia regions (putamen, pallidum) for the
ontrast Disgust > Neutral. Striatum activation has repeatedly been
dentiﬁed during disgust processing (e.g. Calder et al. [18]).
The group contrasting for the Disgust condition revealed no sig-
iﬁcant effect for the selected ROIs. Thus, on the subjective level as
ell as on the neuronal level PD patients and controls did not differ
rom each other.
In the fear condition (contrast: Fear > Neutral) the control par-
icipants showed the expected amygdala activation, whereas noand fear-eliciting pictures (contrasts: Disgust > Neutral, Fear > Neutral).
supra-threshold activation was detected in the clinical group. How-
ever, the group difference was statistically non-signiﬁcant, which
also was  true for the emotion-speciﬁc contrasts Fear > Disgust and
Disgust > Fear, respectively.
It would be interesting to conduct a follow-up study with our
clinical sample in order to ﬁnd out, whether deviations in amyg-
dala responding will occur with increasing symptom duration and
severity. The only group difference for the fear condition concerned
greater pallidum activation in controls relative to patients. Previ-
ous research could not identify a speciﬁc role of this brain region
for fear processing. It is more likely that the lowered activation
is related to reduced grey matter volume. The basal ganglia are
one of the ﬁrst targets of neurodegeneration in PD (e.g., Alexan-
der, [19]). In a morphometric study with the same sample, we  had
detected reduced pallidum volume in the patients, whereas limbic
structures such as the amygdala had not been affected [20]. As the
patients of the present study had also shown marginally reduced
pallidum activation relative to controls for the contrast Dis-
gust > Neutral, this suggests that this effect is not tied to a speciﬁc
emotion.
As a short-coming of our study we have to mention the small
sample size. However, the homogeneity of the clinical sample
is a clear asset. We analyzed data from nondepressed patients
without cognitive impairment, who had discontinued their medi-
cation for the experiment. Previous inconsistent results on affective
processing deﬁcits in PD might be due to the fact that these
possibly confounding variables were not sufﬁciently controlled.
Our ﬁndings suggest that affective experience in PD with mod-
erate symptom severity is not blunted even with longer disease
duration.
In the future, more sophisticated and ecologically valid fMRI
designs (e.g., Bellace et al. [21]) should be used with multisensory
presentations (e.g. visual, acoustic) combined with the analysis of
different processes such as identiﬁcation, experience, and memory
of affective stimuli in PD.
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